JPRN-jRCTs031180324招募中2 期
Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline or Taxan-based Anticancer Drug: Randomized, Double-blind, Placebo controlled Confirmatory study
Hamaguchi Reo0 个研究点目标入组 60 人开始时间: 2019年3月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 70age old（—）
- 性别
- Female
入选标准
- •Agree to undergo adjuvant chemotherapy and plan to receive Doxorubicin/Cyclophosphamide (AC), Epirubicin/Cyclophosphamide (EC), 5-Fluorouracil/Epirubicin/Cyclophosphamide (FEC), Paclitaxel (PTX), nab-Paclitaxel (nab-PTX), Docetaxel (DTX), or Docetaxel/Cyclophosphamide (TC) therapy
排除标准
- •Currently taking dietary supplements derived from basidiomycetes (such as agaricus or health food derived from a mushroom) (allowed if discontinued for more than 7 days before the start of the study)
- •Currently taking dietary supplements except for multivitamins (allowed if discontinued for more than 7 days before the start of the study)
- •Allergy for a health food derived from a mushroom or basidiomycetes
研究者
相似试验
招募中
不适用
Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients Undergoing Anthracycline-based Anticancer Drug as Adjuvant Chemotherapy: Randomized, Double-blind, Placebo controlled, Confirmatory StudyBreast cancerJPRN-UMIN000031386on-Profit Organization JORTC42
已完成
不适用
Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline and Taxane based Adjuvant chemotherapy: Randomized, Double-blind, Placebo controlled, Phase-II StudyPatients receiving adjuvant chemotherapy for breast cancerJPRN-UMIN000015455PO Japanese Organisation for Research and Treatment of Cancer (JORTC)50
尚未招募
2 期
The effect of achillea millefolium on HbA1C and peripheral neuropathy in diabetic patientsIRCT20150713023190N13Rafsanjan University of Medical Sciences70
Unknown
不适用
Efficacy and Safety of HPC-03 for Postmenopausal SymptomPostmenopausal PeriodNCT03061799Jae Hoon Lee150
尚未招募
3 期
oral collagen supplement and i-ipf in patient with temporomandibular joint disorder along with arthrocentesis procedureCTRI/2024/06/068444Vaibhav Alone